Publications by authors named "Catherine Ansquer"

Claim this Profile
A
A Randomized clinical trial evaluating the impact on survival and quality of life of Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217).
Jaume Capdevila, Virginia Pubul, Urbano Anido, Thomas Walter, Javier Molina-Cerrillo, Catherine Ansquer

BMC Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival impact of [Ac]Ac-DOTATOC alpha-therapy in a preclinical model of pancreatic neuroendocrine tumor liver micrometastases.
Alexandre Lugat, Nicolas Chouin, Florian Chocteau, Mathilde Esnault, Séverine Marionneau-Lambot, Catherine Ansquer

Eur J Nucl Med Mol Imaging· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parathyroid near-infrared autofluorescence use for parathyroidectomy in mild primary hyperparathyroidism: Results from a randomized monocentric trial.
Samuel Frey, Sahar Bannani, Cécile Caillard, Maëlle Le Bras, Delphine Drui, Catherine Ansquer

Surgery· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetry and pharmacokinetics of [Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours.
Seval Beykan Schürrle, Uta Eberlein, Catherine Ansquer, Jean-Mathieu Beauregard, Lucie Durand-Gasselin

Eur J Nucl Med Mol Imaging· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of [F]fluorocholine PET/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent/recurrent disease.
Aymeric Boucher, Julia Delabie, Charlotte Lussey-Lepoutre, Magalie Haissaguerre, Eric Ouvrard, Catherine Ansquer

Eur J Nucl Med Mol Imaging· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of the safety and efficacy of [Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours.
Damian Wild, Henning Grønbæk, Shaunak Navalkissoor, Alexander Haug, Guillaume P Nicolas, Catherine Ansquer

Eur J Nucl Med Mol Imaging· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to De Koster and al. Thuillier P, Benisvy D, Ansquer C, Corvilain B, Mirallie E, Taieb D, et al.: What is the role of functional imaging and isotopic treatment? Ann Endocrinol (Paris) 2022. https://doi.org/10.1016/j.ando.2022.10.008.
Philippe Thuillier, Catherine Ansquer, Françoise Borson-Chazot, Charlotte Lussey-Lepoutre

Ann Endocrinol (Paris)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Multicentric Assessment of Ga-DOTANOC PET/CT in Grade 1-2 GEP-NET.
Alexandre Lugat, Éric Frampas, Yann Touchefeu, Éric Mirallié, Maëlle Le Bras, Catherine Ansquer

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : What is the role of functional imaging and isotopic treatment?
Philippe Thuillier, Danielle Benisvy, Catherine Ansquer, Bernard Corvilain, Eric Mirallié

Ann Endocrinol (Paris)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Female Authors in Nuclear Medicine Journals: A Survey from 2014 to 2020.
Charline Lasnon, Gilles Girault, Rachida Lebtahi, Catherine Ansquer, Justine Lequesne

J Nucl Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease.
Clément Mennetrey, Maëlle Le Bras, Aurélie Bando-Delaunay, Laure Al-Mansour, Magalie Haissaguerre, Catherine Ansquer

J Clin Endocrinol Metab· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
123I Scintigraphy Mirror Image of Graves Disease Induced by Radioiodine Treatment for Toxic Adenoma.
Alexandre Lugat, Delphine Drui, Kalyane Bach-Ngohou, Pascale Guillot, Emmanuelle Mourrain-Langlois, Catherine Ansquer

Clin Nucl Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study.
Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher

J Nucl Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carcinoembryonic Antigen Increase in a Patient with Colon Cancer Who Have Achieved Complete Remission and Negative F-FDG PET/CT: Don't Forget the Thyroid!
Alexandre Lugat, Pauline Hulo, Catherine Ansquer, Yann Touchefeu, Eric Mirallié

Curr Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine Tumors.
Catherine Ansquer, Yann Touchefeu, Alain Faivre-Chauvet, Christophe Leux, Maëlle Le Bras

Clin Nucl Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rheumatic involvement and bone scan features in Schnitzler syndrome: initial and follow-up data from a single-center cohort of 25 patients.
Christelle Darrieutort-Laffite, Catherine Ansquer, Hélène Aubert, Françoise Kraeber-Bodéré, Agathe Masseau

Arthritis Res Ther· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of a Second Tc-MIBI Scintigraphy Before Reoperation for Patients With Persistent Sporadic Primary Hyperparathyroidism: Results of a Retrospective Multicenter Study.
Samuel Frey, Clément Couëtte, Christophe Trésallet, Antoine Hamy, Cécile Caillard, Catherine Ansquer

Ann Surg Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with Lu-Dotatate: an analysis of the NETTER-1 study.
Jonathan Strosberg, Pamela L Kunz, Andrew Hendifar, James Yao, David Bushnell, Catherine Ansquer

Eur J Nucl Med Mol Imaging· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of FDG-PET/CT-Based Radiomics for the Characterization and Genetic Orientation of Pheochromocytomas Before Surgery.
Catherine Ansquer, Delphine Drui, Eric Mirallié, Karine Renaudin-Autain, Antoine Denis

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of total thyroidectomy on quality of life at 6 months: the prospective ThyrQoL multicentre trial.
E Mirallié, F Borel, C Tresallet, A Hamy, M Mathonnet, Catherine Ansquer

Eur J Endocrinol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma.
Alexandre Lugat, Delphine Drui, Eric Mirallié, Françoise Kraeber-Bodéré, Catherine Ansquer

Clin Nucl Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture.
Clément Bailly, Caroline Bodet-Milin, Mickaël Bourgeois, Sébastien Gouard, Catherine Ansquer

Cancers (Basel)· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mild sporadic primary hyperparathyroidism: high rate of multiglandular disease is associated with lower surgical cure rate.
Emmanuelle Trébouet, Sahar Bannani, Matthieu Wargny, Christophe Leux, Cécile Caillard, Catherine Ansquer

Langenbecks Arch Surg· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel PET tracers: added value for endocrine disorders.
Sébastien Bergeret, Judith Charbit, Catherine Ansquer, Géraldine Bera, Philippe Chanson

Endocrine· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Solitary Fibrous Tumor With Doege-Potter Syndrome: Hypoglycemia Treated by 90Y Radioembolization.
Clement Bailly, Myriam Bichali Alroumani, Frederic Douane, Catherine Ansquer, Delphine Drui

Clin Nucl Med· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis